Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: J of Cardiovasc Trans Res

Search In Journal Title:

Abbravation: Journal of Cardiovascular Translational Research

Search In Journal Abbravation:

Publisher

Springer US

Search In Publisher:

DOI

10.1002/food.19820260130

Search In DOI:

ISSN

1937-5395

Search In ISSN:
Search In Title Of Papers:

ShortTerm Adjuvant Therapy with Emphasis Type="I

Authors: Divya Kapoor Dimple Trikha Rajesh Vijayvergiya K K Parashar Deepak Kaul Veena Dhawan
Publish Date: 2015/04/01
Volume: 8, Issue: 3, Pages: 173-186
PDF Link

Abstract

The present study evaluated the cardioprotective effects of Terminalia arjuna on classical and immunoinflammatory markers in coronary artery disease CAD as an adjuvant therapy One hundred sixteen patients with stable CAD were administered placebo/T arjuna 500 mg twice a day along with medications in a randomized doubleblind clinical trial To understand the specificity and efficacy of T arjuna we evaluated its effect through microarray and in silico analysis in few representative samples Data was further validated via realtime PCR n = 50 each at baseline 3 months and 6 months respectively rIL18 cytokine was used to induce inflammation in vitro to compare its effects with atorvastatin T arjuna significantly downregulated TG VLDLC and immunoinflammatory markers in stable CAD versus placebotreated subjects Microarray and pathway analysis of a few samples from T arjuna/placebotreated groups and realtime PCR validation further confirmed our observations Our data demonstrate the antiinflammatory and immunomodulatory effects of T arjuna that may attenuate ongoing inflammation and immune imbalance in medicated CAD subjectsWe are grateful to all the study subjects who participated in the present study and the laboratory staff for their technical support We would also like to acknowledge Biovivid Technology Pvt Ltd Bangalore India for their technical support and suggestions in bioinformatics analysisThe authors wish to thank The Himalaya Drug Company Bangalore for providing the drug as well as financial assistance for microarray analysis Also we wish to thank the Indian Council of Medical Research ICMR New Delhi for awarding Senior Research Fellowship to Ms Divya KapoorAll procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation institutional and national and with the Helsinki Declaration of 1975 as revised in 2000 Informed consent was obtained from all patients for being included in the study


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Molecular Cardiology in Translation: Gene, Cell and Chemical-Based Experimental Therapeutics for the Failing Heart
  2. A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening, and Publication Standards
  3. Models of Ventricular Structure and Function Reviewed for Clinical Cardiologists
  4. Bone-Marrow-Derived Side Population Cells for Myocardial Regeneration
  5. Improvement in Cardiovascular Risk Prediction with Electronic Health Records
  6. Emerging MRI Methods in Translational Cardiovascular Research
  7. Letter from the Editors
  8. Determinants of Delayed Preconditioning Against Myocardial Stunning in Chronically Instrumented Pigs
  9. Stem Cell Therapy Trials: A Call for Standardization
  10. A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience
  11. Distinguishing Hypertrophic Cardiomyopathy-Associated Mutations from Background Genetic Noise
  12. Progenitor Cells Confer Plasticity to Cardiac Valve Endothelium
  13. Review of Stem Cell-Based Therapy for the Treatment of Cardiovascular Disease
  14. Right Ventricular Failure—A Continuing Problem in Patients with Left Ventricular Assist Device Support
  15. Clinical, Laboratory, and Pacing Predictors of CRT Response
  16. Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 1): Physiologic and Technical Considerations
  17. Renal Denervation: A Novel Non-pharmacological Approach in Heart Failure
  18. Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
  19. Why Is Infarct Expansion Such an Elusive Therapeutic Target?
  20. ST2-Based Precision Medicine in Device Management: the Next Frontier Beyond MADIT-CRT?
  21. Letter from the Editors

Search Result: